Podophyllotoxin derivatives: Drug discovery and development

Drug Discovery Today

Volumn 1, Issue 8, 1996, Pages 343-351

  Bohlin, Lars ^a   Rosén, Börje ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Conpharm AB ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001635377     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/1359-6446(96)10028-3     Document Type: Review

References (64)

1. Dey, K.L. (1896) in The Indigenous Drugs of India, 2nd Edition, pp. 251-254, Thacker Spink & Co.
2. Chopra, R.N. (1933) in Indigenous of India, pp. 228-231, The Art Press
3. Royle, J.F. (1839) Illustrations of the Botany and other Branches of Natural History of the Himalayan Mountains and the Flora of Cashmere, W.H. Allen & Co.
4. Trease, G.E. and Evans, W.C. (1978) Pharmacognosy, 11th Edition, Baillière-Tindall
5. Anon. The Chinese Flora (1972) Iconographia Cormophytorum Sinicorum, Tomus I, p. 758
6. Catesby, M. (1731) in Natural History of Carolina, Florida and Bahama Islands, Tome 1, p. 24
7. Brunet, O. (1865) in Catalogue des Plantes Canadiennes Contenues dans l'Herbier de l'Université Laval, 1 livraison, Québec, pp. 15-16
8. Fenton, W.N. (1941) Contacts Between Iroquois Herbalism and Colonial Medicine, Smithsonian Report for 1941, publ. 3670
9. Lloyd, J.U. (1911) Pharmacy ser. 4, Bull. 18, 65
10. Bentley, R. (1861) Pharm. J. and Trans. 3, 456-464
11. Bennet, A.R. (1903) Pharm. J. 70, 238
12. Kelly, M. and Hartwell, J. (1954) J. Natl. Cancer Inst. 14 (4), 967-1010
13. Reynolds, J.E.F. (1989) Martindale: The Extra Pharmacopoeia, 29th Edition, pp. 928-929, The Pharmaceutical Press
14. Seino, Y. et al. (1978) Mutat. Res. 58, 225-229
15. Sugimura, T., Nagao, M. and Matsushima, T. (1977) Proc. Japan Acad. 53, Ser B, 194-197
16. Filley, C.H. et al (1982) Neurology 32, 308-311
17. Cullis, J.E. (1962) Lancet ii, 511-512
18. Karol, M.D. et al, (1980) Clin. Toxicol. 16, 283-286
19. Slater, G.E., Rumack, B.H. and Peterson, R.G. (1978) Obstet. Gynecol. 54, 94-96
20. Kaplan, I.W. (1942) New Orleans Med. Surg. J. 94, 388-390
21. Podwissotzki, V. (1881) The Pharmaceutical J. Transactions 217-219
22. Kürsten, R. (1891) Arch. Pharm. 229, 220-248
23. Sullivan, M., Friedman, M. and Hearin, J.T. (1948) South Med. J. 41, 336-337
24. Hartwell, J.L. and Shear, M.J. (1947) J. Cancer Res. 7, 716
25. Stähelin, H. (1970) Eur. J. Cancer 6, 303-311
26. Stähelin, H. (1973) Eur. J. Cancer 9, 215-221
27. Kelleher, J. (1977) Mol. Pharmacol. 13, 232-241
28. Marveel, M. and De Mets, M. (1984) Int. Rev. Cytol. 90, 125-168
29. Margolis, R.L. and Wilson, L. (1981) Nature 293, 705-711
30. Edström, A., Erkell, L.J. and Hansson, H-A. (1975) Virchows Arch. B 19, 101-113
31. Bäck, O. et al. (1978) Scand. J. Haematol. 20, 108-116
32. Loike, J.D. (1982) Cancer Chemother. Pharmacol. 7, 103-111
33. Loike, J.D. et al. (1978) Cancer Res. 38, 2688
34. Truedsson, L., Geborek, P. and Sturfelt, G. (1993) Clin. Exp. Rheumatol. 11, 179-182
35. Norberg, B. and Bäck, O. (1987) Curr. Ther. Res. 41 (2), 173-178
36. Rantapää-Dahlqvist, S. et al. (1994) Br. J. Rheumatol. 33, 327-331
37. Chen, G.L. et al. (1984) J. Biol. Chem. 259 (21), 13560-13566
38. Yalowich, J.C. and Goldman, I.D. (1984) Cancer Res. 44, 984-989
39. Kalwinsky, D.K. et al. (1983) Cancer Res. 43, 1592-1597
40. Crom, W. et al. (1987) Clin. Pharmacokinet. 12, 168-213
41. D'Incalci, M. and Garaffini, S. (1985) Cancer Chemother. 7, 98-104
42. Vogelsang, N.J., Raghavan, D. and Kennedy, B.J. (1982) Am. J. Med. 72, 136-144
43. Loike, J.D. and Horwizt, S.B. (1976) Biochemistry 15, 5443-5448
44. Long, B.N., Musial, S.T. and Brattain, M.G. (1984) Biochemistry 23, 1183-1188
45. Wozniak, A.J. et al. (1984) Cancer Res. 44, 626-632
46. Sinkule, J.A. (1984) Pharmacotherapy 4, 61-73
47. Stähelin, H. (1970) Eur. J. Cancer 6, 303-311
48. Brigati, C. and Sander, B. (1985) J. Immunopharmacol. 7, 285-330
49. Zheng, Q-Y. et al. (1987) Int. J. Immunopharm. 9 (5), 539-549
50. Conpharm AB, Uppsala, Sweden, internal documentation
51. Truedsson, L., Geborek, P. and Sturfelt, G. (1993) Clin. Exp. Rheumatol. 11, 179-182
52. Harvey, V.J. et al. (1984) Proc. Am. Soc. Clin. Oncol. 30; 24 (90)
53. Smyth, R.D., Pfeffer, M. and Scalzo, A. (1985) Semin. Oncol. 12 (Suppl. 2), 48-51
54. D'Incalci, M. et al (1982) Cancer Chemother. Pharmacol. 7, 141-145
55. Evans, W.E. et al. (1981) Proc. Am. Assoc. Cancer Res. 22, 174 (690)
56. Colombo, T. et al. (1986) Eur. J. Cancer Clin. Oncol. 22, 173-179
57. Allen, L.M. and Creaven, P.J. (1975) Eur. J. Cancer 11, 697-707
58. Creaven, P.J. (1982) Cancer Chemother. Pharmacol. 7, 133-140
59. Creaven, P.J. and Allen, L.M. (1975) Clin. Pharmacol. Ther. 18, 227-233
60. Lassus, A. and Rosén, B. (1986) Dermatologica 172, 319-322
61. United States Patent - Medicinal Uses for Podophyllotoxins. Patent number 4,788,216
62. Fassbender, H.G. (1986) EULAR Bulletin 2, 59-65
63. Larsen, A., Petersson, I. and Svensson, B. (1989) Br. J. Rheumatol. 28, 124-127
64. Rogers, J. et al. (1993) Neurology 43, 1609-1611